"We are delighted to have an industry visionary and strategic thinker such as Bill Louv join the DDN Advisory Board", stated Alex Bouzari, CEO and cofounder, DataDirect Networks. "Bill's deep understanding of global IT, business intelligence and analytics tools brings tremendous value to DDN's strategic expansion into data-driven markets on a global scale."
DDN's customers include 60 percent of the world's Top 50 fastest supercomputers and many other high performance computing leaders, as well as leading Web companies, media organizations, and security and intelligence organisations. DDN was recently named America's fastest growing computer company with more than $100 million in annual revenue byInc. Magazine.
"DDN is on the leading edge of a revolution that is redefining how we capture, process and gain insight from data", Bill Louv stated. "For more than a decade, DDN has been a beacon for organisations in every industry wanting to push the boundaries of what can be accomplished with the massive amount of information they produce, and I am tremendously pleased to join the Advisory Board as big data becomes democratized across all of the enterprise."
Prior to joining GlaxoSmithKline, Bill Louv held leadership positions at Marion Merrell Dow, including Vice President of Global Statistics and Clinical Data Management. He has also served as Associate Professor of Epidemiology at the University of Alabama School of Public Health and as Member of Technical Staff, Signaling Systems Engineering for Bell Labs.
Bill Louv holds a Bachelor of Science degree in Biology from the College of William and Mary, and Master of Science and Doctor of Philosophy degrees in Statistics from the University of Florida.